サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1671160

マラリアワクチンの世界市場：市場規模・シェア・動向、業界分析 (ワクチンの種類別・投与経路別・対象人口別・予防接種スケジュール別・開発段階別・地域別)、将来予測 (2025年～2034年)

Malaria Vaccines Market Size, Share, Trends, Industry Analysis Report: By Vaccine Type, Administration Route, Target Population, Immunization Schedule, Development Stage, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 114 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
マラリアワクチンの世界市場：市場規模・シェア・動向、業界分析 (ワクチンの種類別・投与経路別・対象人口別・予防接種スケジュール別・開発段階別・地域別)、将来予測 (2025年～2034年)
出版日: 2025年02月01日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のマラリアワクチンの市場規模は2034年までに16億1,987万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

マラリアは、感染した蚊に刺されることでヒトからヒトへと感染する原虫によって引き起こされる、生命を脅かす深刻な病気です。蚊が媒介するこの病気は、子供や大人に深刻な病気を引き起こします。特に妊婦や子供はマラリアによる発熱に弱いです。この病気を防ぐための様々な予防策には、防虫ネットの使用や殺虫剤の散布などがあります。しかし、現在の調査研究では、昆虫は殺虫剤に免疫があること、殺虫剤は人体に有害な影響を及ぼすこと、マラリア熱は薬が効かなくなってきていることなどが明らかになっています。こうした課題を受けて、研究者や製薬会社は代替予防法としてマラリアワクチンの開発に取り組んでいます。

世界のマラリア罹患率の上昇や、製薬会社による低価格マラリアワクチンの世界の導入など、いくつかの要因がマラリアワクチン市場の成長を促進しています。この病気の影響に関する意識の高まりや、研究開発（R&D）の継続的な取り組みが、市場開拓をさらに後押ししています。

一部のマラリア流行途上国における脆弱なサプライチェーンや流通網の問題に対処するための政府機関や民間団体による開発の高まりは、マラリアワクチンの採用を後押しすると予想されます。接種プログラムの増加や革新的なワクチン技術の開発が重視されていることから、今後数年間はマラリアワクチン市場にいくつかの市場機会がもたらされると予想されます。

マラリアワクチン市場：分析概要

ワクチンの種類別では、RTS,S/AS01ワクチンの有効性を実証する広範な臨床研究と臨床試験、およびアフリカ諸国での展開により、RTS,S/AS01分野が2024年のマラリアワクチン市場収益の最大シェアを占めました。

投与経路別では、筋肉内投与がR21/Matrix-MやRTS,S/AS01を含むマラリアワクチンの投与に最も広く使用されているため、2024年のマラリアワクチン市場シェアは筋肉内投与がリードしました。

北米は、マラリアワクチン開発プログラムに多額の投資を行っている主要製薬企業の強い存在感と、マラリアワクチンの研究開発イニシアチブを支援する有利な政府規制の導入により、2024年のマラリアワクチン市場を牽引しました。

中東・アフリカのマラリアワクチン市場は、2025年から2034年にかけて大幅なCAGRを記録すると予測されます。これは、医療インフラ整備への注目の高まりと、費用対効果の高いマラリアワクチン開発のための政府・民間組織間の連携強化が背景にあります。

Instituto Butantan、Merck、PATH、GSK、Vaxart、Biovac、Pfizer、Inovio Pharmaceuticals、Bharat Biotech、University of Oxford、Intellia Therapeutics、Johnson &Johnson、Sanaria、武田薬品工業は、この市場における主要企業の一例です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界のマラリアワクチン市場の洞察

  • 市場スナップショット
  • マラリアワクチンの市場力学
    • 促進要因と機会
      • 低所得国におけるマラリアの蔓延拡大
      • 資金と投資の増加
    • 抑制要因と課題
      • 医薬品の開発と流通にかかる高コスト
  • PESTLE分析
  • マラリアワクチン市場の応用動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のマラリアワクチン市場：ワクチンの種類別

  • 主な分析結果
  • イントロダクション
  • ペルー
  • RTS,S/AS01　
  • R21/マトリックスM

第6章 世界のマラリアワクチン市場：投与経路別

  • 主な分析結果
  • イントロダクション
  • 皮下
  • 筋肉内

第7章 世界のマラリアワクチン市場：対象人口別

  • 主な分析結果
  • イントロダクション
  • 流行地域への旅行者
  • 妊婦
  • 5歳未満の小児

第8章 世界のマラリアワクチン市場：予防接種スケジュール別

  • 主な分析結果
  • イントロダクション
  • 単回接種
  • 多回接種
  • 追加接種

第9章 世界のマラリアワクチン市場：開発段階別

  • 主な分析結果
  • イントロダクション
  • 前臨床
  • 臨床試験

第10章 世界のマラリアワクチン市場：地域別

  • 主な分析結果
  • イントロダクション
    • マラリアワクチン市場の評価：地域別 (2020～2034年)
  • 北米
    • 北米：ワクチンの種類別 (2020～2034年)
    • 北米：投与経路別 (2020～2034年)
    • 北米：対象人口別 (2020～2034年)
    • 北米：予防接種スケジュール別 (2020～2034年)
    • 北米：開発段階別 (2020～2034年)
    • 米国
    • カナダ
  • 欧州
    • 欧州：ワクチンの種類別 (2020～2034年)
    • 欧州：投与経路別 (2020～2034年)
    • 欧州：対象人口別 (2020～2034年)
    • 欧州：予防接種スケジュール別 (2020～2034年)
    • 欧州：開発段階別 (2020～2034年)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：ワクチンの種類別 (2020～2034年)
    • アジア太平洋地域：投与経路別 (2020～2034年)
    • アジア太平洋地域：対象人口別 (2020～2034年)
    • アジア太平洋地域：予防接種スケジュール別 (2020～2034年)
    • アジア太平洋地域：開発段階別 (2020～2034年)
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：ワクチンの種類別 (2020～2034年)
    • 中東・アフリカ：投与経路別 (2020～2034年)
    • 中東・アフリカ：対象人口別 (2020～2034年)
    • 中東・アフリカ：予防接種スケジュール別 (2020～2034年)
    • 中東・アフリカ：開発段階別 (2020～2034年)
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：ワクチンの種類別 (2020～2034年)
    • ラテンアメリカ：投与経路別 (2020～2034年)
    • ラテンアメリカ：対象人口別 (2020～2034年)
    • ラテンアメリカ：予防接種スケジュール別 (2020～2034年)
    • ラテンアメリカ：開発段階別 (2020～2034年)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第11章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第12章 企業プロファイル

  • Instituto Butantan
  • Merck
  • PATH
  • GSK
  • Vaxart
  • Biovac
  • Pfizer
  • Inovio Pharmaceuticals
  • Bharat Biotech
  • University of Oxford
  • Intellia Therapeutics
  • Johnson & Johnson
  • Sanaria
  • Takeda Pharmaceutical Company
図表

List of Tables:

  • Table 1 Global Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 2 Global Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 3 Global Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 4 Global Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 5 Global Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 6 North America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 7 North America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 8 North America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 9 North America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 10 North America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 11 US: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 12 US: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 13 US: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 14 US: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 15 US: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 16 Canada: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 17 Canada: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 18 Canada: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 19 Canada: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 20 Canada: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 21 Europe: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 22 Europe: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 23 Europe: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 24 Europe: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 25 Europe: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 26 UK: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 27 UK: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 28 UK: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 29 UK: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 30 UK: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 31 France: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 32 France: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 33 France: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 34 France: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 35 France: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 36 Germany: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 37 Germany: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 38 Germany: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 39 Germany: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 40 Germany: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 41 Italy: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 42 Italy: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 43 Italy: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 44 Italy: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 45 Italy: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 46 Spain: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 47 Spain: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 48 Spain: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 49 Spain: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 50 Spain: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 51 Netherlands: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 52 Netherlands: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 53 Netherlands: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 54 Netherlands: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 55 Netherlands: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 56 Russia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 57 Russia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 58 Russia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 59 Russia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 60 Russia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 61 Rest of Europe: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 62 Rest of Europe: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 63 Rest of Europe: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 64 Rest of Europe: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 65 Rest of Europe: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 66 Asia Pacific: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 67 Asia Pacific: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 68 Asia Pacific: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 69 Asia Pacific: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 70 Asia Pacific: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 71 China: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 72 China: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 73 China: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 74 China: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 75 China: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 76 India: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 77 India: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 78 India: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 79 India: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 80 India: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 81 Malaysia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 82 Malaysia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 83 Malaysia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 84 Malaysia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 85 Malaysia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 86 Japan: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 87 Japan: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 88 Japan: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 89 Japan: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 90 Japan: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 91 Indonesia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 92 Indonesia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 93 Indonesia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 94 Indonesia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 95 Indonesia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 96 South Korea: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 97 South Korea: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 98 South Korea: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 99 South Korea: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 100 South Korea: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 101 Australia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 102 Australia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 103 Australia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 104 Australia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 105 Australia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 106 Rest of Asia Pacific: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 107 Rest of Asia Pacific: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 108 Rest of Asia Pacific: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 109 Rest of Asia Pacific: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 110 Rest of Asia Pacific: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 111 Middle East & Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 112 Middle East & Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 113 Middle East & Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 114 Middle East & Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 115 Middle East & Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 116 Saudi Arabia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 117 Saudi Arabia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 118 Saudi Arabia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 119 Saudi Arabia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 120 Saudi Arabia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 121 UAE: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 122 UAE: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 123 UAE: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 124 UAE: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 125 UAE: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 126 Israel: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 127 Israel: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 128 Israel: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 129 Israel: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 130 Israel: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 131 South Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 132 South Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 133 South Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 134 South Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 135 South Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 136 Rest of Middle East & Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 137 Rest of Middle East & Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 138 Rest of Middle East & Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 139 Rest of Middle East & Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 140 Rest of Middle East & Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 141 Latin America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 142 Latin America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 143 Latin America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 144 Latin America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 145 Latin America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 146 Mexico: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 147 Mexico: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 148 Mexico: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 149 Mexico: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 150 Mexico: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 151 Brazil: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 152 Brazil: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 153 Brazil: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 154 Brazil: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 155 Brazil: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 156 Argentina: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 157 Argentina: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 158 Argentina: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 159 Argentina: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 160 Argentina: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 161 Rest of Latin America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 162 Rest of Latin America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 163 Rest of Latin America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 164 Rest of Latin America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 165 Rest of Latin America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Malaria Vaccines Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Vaccine Type
  • Figure 7. Global Malaria Vaccines Market, by Vaccine Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Administration Route
  • Figure 9. Global Malaria Vaccines Market, by Administration Route, 2024 & 2034 (USD Million)
  • Figure 10. Market by Target Population
  • Figure 11. Global Malaria Vaccines Market, by Target Population, 2024 & 2034 (USD Million)
  • Figure 12. Market by Immunization Schedule
  • Figure 13. Global Malaria Vaccines Market, by Immunization Schedule, 2024 & 2034 (USD Million)
  • Figure 14. Market by Development Stage
  • Figure 15. Global Malaria Vaccines Market, by Development Stage, 2024 & 2034 (USD Million)
目次
Product Code: PM1525

The global malaria vaccines market size is expected to reach USD 1,619.87 million by 2034, according to a new study by Polaris Market Research. The report "Malaria Vaccines Market Size, Share, Trends, Industry Analysis Report: By Vaccine Type, Administration Route (Subcutaneous and Intramuscular), Target Population, Immunization Schedule, Development Stage, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Malaria is a serious, life-threatening disease caused by Plasmodium parasite, which is transmitted from human to human by the bite of infected mosquitoes. This mosquito-borne illness causes severe disease in kids and adults. Pregnant women and children are particularly vulnerable to the fever caused by malaria. Various precautions to control the disease include the use of insect nets and spraying of pesticides. However, current research studies have shown that insects are immune to pesticides, pesticides have harmful effects on human beings, and malaria fever is becoming immune to medications. In response to these challenges, researchers and pharmaceutical companies have been working on the development of malaria vaccines as an alternative method of prevention.

Several factors, such as the rising incidence of malaria worldwide and the introduction of low-cost malaria vaccines by pharma companies globally, are driving the malaria vaccines market growth. Rising awareness about the disease's consequences and ongoing research and development (R&D) initiatives are further supporting the market development.

Growing efforts by government and private organizations to address the issues of weak supply chains and distribution networks in some malaria-endemic developing countries are expected to boost the adoption of malaria vaccines. Rising inoculation programs and emphasis on the development of innovative vaccine technologies are expected to provide several malaria vaccines market opportunities in the coming years.

Key Highlights of Malaria Vaccines Market Report

Based on vaccine type, the RTS,S/AS01 segment held the largest share of the malaria vaccines market revenue in 2024, owing to the extensive clinical research and trials demonstrating the efficacy of RTS, S/AS01 vaccines, and their rollout in various African countries.

By administration route, the intramuscular segment led the malaria vaccines market share in 2024 as intramuscular is the most widely used route for administrating malaria vaccines, including R21/Matrix-M and RTS,S/AS01.

North America led the market for malaria vaccines in 2024, driven by the strong presence of leading pharma companies with significant investments in malaria vaccine development programs and the introduction of favorable government regulations supporting malaria vaccine R&D initiatives.

The Middle East & Africa malaria vaccines market is projected to witness a significant CAGR from 2025 to 2034, driven by the rising focus on improving healthcare infrastructure and enhanced collaborations between government and private organizations to develop cost-effective malaria vaccines.

Instituto Butantan, Merck, PATH, GSK, Vaxart, Biovac, Pfizer, Inovio Pharmaceuticals, Bharat Biotech, University of Oxford, Intellia Therapeutics, Johnson & Johnson, Sanaria, and Takeda Pharmaceutical Company are a few of the key players in the market.

Polaris Market Research has segmented the malaria vaccines market research report on the basis of vaccine type, administration route, target population, immunization schedule, development stage, and region:

By Vaccine Type Outlook (Revenue - USD Million, 2020-2034)

  • PfSPZ
  • RTS,S/AS01
  • R21/Matrix-M

By Administration Route Outlook (Revenue - USD Million, 2020-2034)

  • Subcutaneous
  • Intramuscular

By Target Population Outlook (Revenue - USD Million, 2020-2034)

  • Travelers to Endemic Areas
  • Pregnant Women
  • Children under 5 Years

By Immunization Schedule Outlook (Revenue - USD Million, 2020-2034)

  • Single Dose
  • Multi-Dose
  • Booster Doses

By Development Stage Outlook (Revenue - USD Million, 2020-2034)

  • Preclinical
  • Clinical Trials

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Malaria Vaccines Market Insights

  • 4.1. Malaria Vaccines Market - Application Snapshot
  • 4.2. Malaria Vaccines Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Prevalence of Malaria in Low-Income Countries
      • 4.2.1.2. Increasing Funding and Investment
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Drug Development and Distribution
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry Among Existing Firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Malaria Vaccines Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Malaria Vaccines Market, by Vaccine Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • 5.3. PfSPZ
    • 5.3.1. Global Malaria Vaccines Market, by PfSPZ, by Region, 2020-2034 (USD Million)
  • 5.4. RTS,S/AS01
    • 5.4.1. Global Malaria Vaccines Market, by RTS,S/AS01, by Region, 2020-2034 (USD Million)
  • 5.5. R21/Matrix-M
    • 5.5.1. Global Malaria Vaccines Market, by R21/Matrix-M, by Region, 2020-2034 (USD Million)

6. Global Malaria Vaccines Market, by Administration Route

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • 6.3. Subcutaneous
    • 6.3.1. Global Malaria Vaccines Market, by Subcutaneous, by Region, 2020-2034 (USD Million)
  • 6.4. Intramuscular
    • 6.4.1. Global Malaria Vaccines Market, by Intramuscular, by Region, 2020-2034 (USD Million)

7. Global Malaria Vaccines Market, by Target Population

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • 7.3. Travelers to Endemic Areas
    • 7.3.1. Global Malaria Vaccines Market, by Travelers to Endemic Areas, by Region, 2020-2034 (USD Million)
  • 7.4. Pregnant Women
    • 7.4.1. Global Malaria Vaccines Market, by Pregnant Women, by Region, 2020-2034 (USD Million)
  • 7.5. Children Under 5 years
    • 7.5.1. Global Malaria Vaccines Market, by Children Under 5 years, by Region, 2020-2034 (USD Million)

8. Global Malaria Vaccines Market, by Immunization Schedule

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • 8.3. Single Dose
    • 8.3.1. Global Malaria Vaccines Market, by Single Dose, by Region, 2020-2034 (USD Million)
  • 8.4. Multi-Dose
    • 8.4.1. Global Malaria Vaccines Market, by Multi-Dose, by Region, 2020-2034 (USD Million)
  • 8.5. Booster Doses
    • 8.5.1. Global Malaria Vaccines Market, by Booster Doses, by Region, 2020-2034 (USD Million)

9. Global Malaria Vaccines Market, by Development Stage

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • 9.3. Preclinical
    • 9.3.1. Global Malaria Vaccines Market, by Preclinical, by Region, 2020-2034 (USD Million)
  • 9.4. Clinical Trials
    • 9.4.1. Global Malaria Vaccines Market, by Clinical Trials, by Region, 2020-2034 (USD Million)

10. Global Malaria Vaccines Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Malaria Vaccines Market Assessment, by Geography, 2020-2034 (USD Million)
  • 10.3. Malaria Vaccines Market - North America
    • 10.3.1. North America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
    • 10.3.2. North America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
    • 10.3.3. North America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
    • 10.3.4. North America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
    • 10.3.5. North America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.3.6. Malaria Vaccines Market - US
      • 10.3.6.1. US: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.3.6.2. US: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.3.6.3. US: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.3.6.4. US: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.3.6.5. US: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.3.7. Malaria Vaccines Market - Canada
      • 10.3.7.1. Canada: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.3.7.2. Canada: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.3.7.3. Canada: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.3.7.4. Canada: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.3.7.5. Canada: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • 10.4. Malaria Vaccines Market - Europe
    • 10.4.1. Europe: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
    • 10.4.2. Europe: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
    • 10.4.3. Europe: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
    • 10.4.4. Europe: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
    • 10.4.5. Europe: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.6. Malaria Vaccines Market - UK
      • 10.4.6.1. UK: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.6.2. UK: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.6.3. UK: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.6.4. UK: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.6.5. UK: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.7. Malaria Vaccines Market - France
      • 10.4.7.1. France: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.7.2. France: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.7.3. France: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.7.4. France: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.7.5. France: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.8. Malaria Vaccines Market - Germany
      • 10.4.8.1. Germany: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.8.2. Germany: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.8.3. Germany: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.8.4. Germany: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.8.5. Germany: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.9. Malaria Vaccines Market - Italy
      • 10.4.9.1. Italy: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.9.2. Italy: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.9.3. Italy: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.9.4. Italy: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.9.5. Italy: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.10. Malaria Vaccines Market - Spain
      • 10.4.10.1. Spain: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.10.2. Spain: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.10.3. Spain: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.10.4. Spain: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.10.5. Spain: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.11. Malaria Vaccines Market - Netherlands
      • 10.4.11.1. Netherlands: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.11.2. Netherlands: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.11.3. Netherlands: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.11.4. Netherlands: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.11.5. Netherlands: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.12. Malaria Vaccines Market - Russia
      • 10.4.12.1. Russia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.12.2. Russia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.12.3. Russia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.12.4. Russia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.12.5. Russia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.13. Malaria Vaccines Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.13.2. Rest of Europe: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.13.3. Rest of Europe: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.13.4. Rest of Europe: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.13.5. Rest of Europe: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • 10.5. Malaria Vaccines Market - Asia Pacific
    • 10.5.1. Asia Pacific: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
    • 10.5.2. Asia Pacific: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
    • 10.5.3. Asia Pacific: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
    • 10.5.4. Asia Pacific: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
    • 10.5.5. Asia Pacific: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.6. Malaria Vaccines Market - China
      • 10.5.6.1. China: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.6.2. China: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.6.3. China: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.6.4. China: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.6.5. China: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.7. Malaria Vaccines Market - India
      • 10.5.7.1. India: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.7.2. India: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.7.3. India: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.7.4. India: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.7.5. India: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.8. Malaria Vaccines Market - Malaysia
      • 10.5.8.1. Malaysia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.8.2. Malaysia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.8.3. Malaysia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.8.4. Malaysia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.8.5. Malaysia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.9. Malaria Vaccines Market - Japan
      • 10.5.9.1. Japan: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.9.2. Japan: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.9.3. Japan: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.9.4. Japan: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.9.5. Japan: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.10. Malaria Vaccines Market - Indonesia
      • 10.5.10.1. Indonesia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.10.2. Indonesia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.10.3. Indonesia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.10.4. Indonesia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.10.5. Indonesia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.11. Malaria Vaccines Market - South Korea
      • 10.5.11.1. South Korea: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.11.2. South Korea: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.11.3. South Korea: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.11.4. South Korea: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.11.5. South Korea: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.12. Malaria Vaccines Market - Australia
      • 10.5.12.1. Australia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.12.2. Australia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.12.3. Australia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.12.4. Australia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.12.5. Australia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.13. Malaria Vaccines Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.13.2. Rest of Asia Pacific: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.13.3. Rest of Asia Pacific: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.13.4. Rest of Asia Pacific: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.13.5. Rest of Asia Pacific: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • 10.6. Malaria Vaccines Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
    • 10.6.2. Middle East & Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
    • 10.6.3. Middle East & Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
    • 10.6.4. Middle East & Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
    • 10.6.5. Middle East & Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.6.6. Malaria Vaccines Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.6.6.2. Saudi Arabia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.6.6.3. Saudi Arabia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.6.6.4. Saudi Arabia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.6.6.5. Saudi Arabia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.6.7. Malaria Vaccines Market - UAE
      • 10.6.7.1. UAE: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.6.7.2. UAE: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.6.7.3. UAE: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.6.7.4. UAE: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.6.7.5. UAE: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.6.8. Malaria Vaccines Market - Israel
      • 10.6.8.1. Israel: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.6.8.2. Israel: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.6.8.3. Israel: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.6.8.4. Israel: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.6.8.5. Israel: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.6.9. Malaria Vaccines Market - South Africa
      • 10.6.9.1. South Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.6.9.2. South Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.6.9.3. South Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.6.9.4. South Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.6.9.5. South Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.6.10. Malaria Vaccines Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.6.10.2. Rest of Middle East & Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.6.10.3. Rest of Middle East & Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.6.10.4. Rest of Middle East & Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.6.10.5. Rest of Middle East & Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • 10.7. Malaria Vaccines Market - Latin America
    • 10.7.1. Latin America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
    • 10.7.2. Latin America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
    • 10.7.3. Latin America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
    • 10.7.4. Latin America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
    • 10.7.5. Latin America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.7.6. Malaria Vaccines Market - Mexico
      • 10.7.6.1. Mexico: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.7.6.2. Mexico: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.7.6.3. Mexico: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.7.6.4. Mexico: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.7.6.5. Mexico: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.7.7. Malaria Vaccines Market - Brazil
      • 10.7.7.1. Brazil: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.7.7.2. Brazil: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.7.7.3. Brazil: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.7.7.4. Brazil: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.7.7.5. Brazil: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.7.8. Malaria Vaccines Market - Argentina
      • 10.7.8.1. Argentina: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.7.8.2. Argentina: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.7.8.3. Argentina: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.7.8.4. Argentina: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.7.8.5. Argentina: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.7.9. Malaria Vaccines Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.7.9.2. Rest of Latin America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.7.9.3. Rest of Latin America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.7.9.4. Rest of Latin America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.7.9.5. Rest of Latin America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Instituto Butantan
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Merck
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. PATH
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. GSK
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Vaxart
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Biovac
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Pfizer
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Inovio Pharmaceuticals
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Bharat Biotech
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. University of Oxford
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Intellia Therapeutics
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Johnson & Johnson
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Sanaria
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development
  • 12.14. Takeda Pharmaceutical Company
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Benchmarking
    • 12.14.4. Recent Development